| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 57.528 | 58.323 | 82.825 | 110.944 |
| Total Income - EUR | - | - | - | - | - | - | 57.849 | 58.696 | 82.846 | 110.944 |
| Total Expenses - EUR | - | - | - | - | - | - | 38.626 | 41.719 | 46.305 | 112.715 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 19.223 | 16.977 | 36.541 | -1.771 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 18.756 | 16.390 | 35.712 | -3.102 |
| Employees | - | - | - | - | - | - | 2 | 0 | 2 | 4 |
Check the financial reports for the company - Epi Clinique Pro S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 21.767 | 22.353 | 22.828 | 14.773 |
| Current Assets | - | - | - | - | - | - | 3.119 | 2.763 | 18.350 | 11.611 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 275 | 2.129 | 6.353 |
| Cash | - | - | - | - | - | - | 3.119 | 2.488 | 16.221 | 5.258 |
| Shareholders Funds | - | - | - | - | - | - | 18.796 | 16.444 | 35.761 | 17.135 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 5.720 | 8.673 | 5.417 | 9.249 |
| Income in Advance | - | - | - | - | - | - | 370 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9622 - 9622" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Epi Clinique Pro S.r.l.